Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-a norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort

International Journal of Epidemiology

Volumn 42, Issue 1, 2013, Pages 201-210

  De Vogel, Stefan ^a   Meyer, Klaus ^b   Fredriksen, Ase ^b   Ulvik, Arve ^b   Ueland, Per Magne ^a,c   Nygård, Ottar ^a,c   Vollset, Stein Emil ^a,d   Tell, Grethe S ^a   Tretli, Steinar ^e   Bjørge, Tone ^a,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b BEVITAL AS   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Folate; Population based case control study; Prostate cancer risk; Vitamin b12

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHYLMALONIC ACID;

CANCER; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); DISEASE CONTROL; HEALTH RISK; META-ANALYSIS; OXIDATION; REGRESSION ANALYSIS; RISK FACTOR; SAMPLING; SERUM; VITAMIN;

ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLIC ACID BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYDROLYSIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATION; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN DEGRADATION; RISK REDUCTION; SEDENTARY LIFESTYLE; VITAMIN BLOOD LEVEL; WILD TYPE;

ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NORWAY; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; SOCIOECONOMIC FACTORS; VITAMIN B 12;

NORWAY;

EID: 84875630861     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys199     Document Type: Article

References (46)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Kvale R, Auvinen A, Adami HO et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99: 1881-87.
3. Kvale R, Moller B, Angelsen A et al. Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007. Cancer Epidemiol 2010;34:359-67.
4. Ulrich CM, Grady WM. Linking epidemiology to epigenomics-where are we today Cancer Prev Res (Phila) 2010;3:1505-08.
5. Collin SM, Metcalfe C, Refsum H et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:1632-42.
6. Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 2005;113:819-24.
7. Johansson M, Appleby PN, Allen NE et al. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol Biomarkers Prev 2008; 17:279-85.
8. Johansson M, Van Guelpen B, Vollset SE et al. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomarkers Prev 2009; 18:1538-43.
9. Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R et al. Null association between prostate cancer and serum folate, vitamin B6, vitamin B12, and homocysteine. Cancer Epidemiol Biomarkers Prev 2003;12(11 Pt 1): 1271-72.
10. Tomaszewski JJ, Cummings JL, Parwani AV et al. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate 2011; 71:1287-93.
11. Collin SM, Metcalfe C, Refsum H et al. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Cancer Epidemiol Biomarkers Prev 2010;19:2833-38.
12. Cole BF, Baron JA, Sandler RS et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-59.
13. Ebbing M, Bonaa KH, Nygard O et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009;302:2119-26.
14. Figueiredo JC, Grau MV, Haile RW et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009;101:432-35.
15. Armitage JM, Bowman L, Clarke RJ et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010; 303:2486-94.
16. Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77.
17. Pelucchi C, Galeone C, Talamini R et al. Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev 2005;14:944-48.
18. Shannon J, Phoutrides E, Palma A et al. Folate intake and prostate cancer risk: a case-control study. Nutr Cancer 2009;61:617-28.
19. Stevens VL, Rodriguez C, Pavluck AL, McCullough ML, Thun MJ, Calle EE. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006;163:989-96.
20. Weinstein SJ, Stolzenberg-Solomon R, Pietinen P, Taylor PR, Virtamo J, Albanes D. Dietary factors of one-carbon metabolism and prostate cancer risk. Am J Clin Nutr 2006;84:929-35.
21. Hannisdal R, Svardal A, Ueland PM. Measurement of folate in fresh and archival serum samples as p-aminobenzoylglutamate equivalents. Clin Chem 2008; 54:665-72.
22. Janus Serum Bank. http://www.kreftregisteret.no/en/Research/Janus-Serum-Bank/(27 March 2012, date last accessed).
23. Metabolites and Vitamins. http://www.bevital.no/(27 March 2012, date last accessed).
24. Gislefoss RE, Grimsrud TK, Morkrid L. Long-term stability of serum components in the Janus Serum Bank. Scand J Clin Lab Invest 2008;68:402-09.
25. Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Morkrid L, Ueland PM. Analytical recovery of folate and its degradation products in human serum stored at _258C for up to 29 years. J Nutr 2010;140: 522-26.
26. Hannisdal R, Ueland PM, Svardal A. Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum. Clin Chem 2009;55:1147-54.
27. Hustad S, Eussen S, Midttun O et al. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012;58:402-10.
28. Windelberg A, Arseth O, Kvalheim G, Ueland PM. Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem 2005;51:2103-09.
29. Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991;44:592-95.
30. Meyer K, Fredriksen A, Ueland PM. High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry. Clin Chem 2004;50:391-402.
31. Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a metaanalysis of 24 prospective cohort studies. Am J Public Health 2010;100:693-701.
32. Liu Y, Hu F, Li D et al. Does physical activity reduce the risk of prostate cancer A systematic review and metaanalysis. Eur Urol 2011;60:1029-44.
33. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2011;4: 486-501.
34. Ulvik A, Ebbing M, Hustad S et al. Long-and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clin Chem 2010;56:755-63.
35. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007;51:267-92.
36. Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007;28: 856-65.
37. Collin SM, Metcalfe C, Zuccolo L et al. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2009;18:2528-39.
38. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C-4 T and methionine synthase 2756A-4G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004;13:2175-80.
39. Hubner RA, Houlston RS. MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 2007;120:1027-35.
40. Ulrich CM, Neuhouser M, Liu AY et al. Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev 2008;17:1822-31.
41. Clarke R, Shipley M, Lewington S et al. Underestimation of risk associations due to regression dilution in longterm follow-up of prospective studies. Am J Epidemiol 1999;150:341-53.
42. Clarke R, Halsey J, Lewington S et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 2010;170:1622-31.
43. Wien TN, Pike E, Wisloff T, Staff A, Smeland S, Klemp M. Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open 2012;2:e000653.
44. Andreeva VA, Touvier M, Kesse-Guyot E, Julia C, Galan P, Hercberg S. B vitamin and/or omega-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial. Arch Intern Med 2012;172:540-47.
45. Hankey GJ, Eikelboom JW, Yi Q et al. Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial. Stroke 2012;43:1572-77.
46. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr 1999;19:357-77.